Healthcare -
Biotechnology - NASDAQ - US
$ 1.71
-8.56 %
$ 386 M
Market Cap
-1.47
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Sana Biotechnology, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 282 M |
| Operating Income | -273 M |
| Other Expenses | -5.96 M |
| Net Income | -267 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 0 | 30.9 | 27.7 | 17.9 | 10.2 | 3.9 | 1 K |
| Gross Profit | 0 | (30.9) | (27.7) | (17.9) | (10.2) | (3.9) | 1 K |
| OPERATING INCOME | |||||||
| Operating Expenses | 281.6 | 294.9 | 272.6 | 356.9 | 286.1 | 141.2 | 8.2 |
| Selling, General and Administrative Expenses | 64.0 | 73.3 | 71.6 | 50.4 | 28.3 | 21.8 | 4.2 |
| Research and Development Expenses | 191.9 | 221.6 | 201.0 | 306.5 | 257.9 | 119.4 | 4.0 |
| Operating Income | (272.7) | (326.9) | (272.6) | (356.9) | (286.1) | (141.2) | (8.2) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 6.0 | 43.6 | 3.1 | 1.0 | 0.8 | 2.8 | (5.0) |
| Pre-Tax Income | (266.8) | (283.3) | (269.5) | (355.9) | (285.3) | (138.3) | (13.2) |
| NET INCOME | |||||||
| Tax Provision | 0 | 0 | (3.1) | (11.7) | (6.7) | (7.5) | 0 |
| Net Income | (266.8) | (283.3) | (266.4) | (344.2) | (278.6) | (130.8) | (13.2) |
| EPS | 1.16 | 1.46 | 1.41 | 2.07 | 1.49 | 0.7 | 0.0707 |